|
Houston Spine and Disc: Spinal Research
VAX-D Research Overview
Results of multiple clinical studies have demonstrated that VAX-D is an effective treatment for the
management of chronic low back pain. A retrospective outcome study on 778 patients, a Phase II Randomized Controlled Trial and a study
conducted in a neurosurgery practice on the number of treatments for success, all reported approximately 70% success rates and improvements in
functional outcomes for patients suffering from disc related chronic back pain.
A two-year study sponsored by Independence Blue Cross has just been released in 2008. The
purpose was to determine short- and long-term outcomes after VAX-D treatment in a large sample of patients with activity-limiting low back pain
that had failed at least two previous, non-surgical treatments. The study showed that patients had significantly improved pain and
disability scores at the end of treatment, at 30 days and at 180 days post-discharge.
In addition, several research articles have been published examining the mechanism of action of
VAX-D. Studies on the effects of VAX-D on intradiscal pressures have been reported, and it’s effects on sensory nerve dysfunction in
patients with low back pain and radiculopathy have been published.
Dermatomal Somatosensory Evoked Potentials (DSSEP’s) were used to demonstrate lumbar nerve
root decompression following VAX-D Therapy.
VAX-D Medical Technologies has been at the forefront of research in spinal pain (low back and
cervical pathology). VAX-D has had a long history of peer reviewed clinical studies published on different aspects of the treatment.
The VAX-D system is being utilized by physicians in Orthopedic Medicine, Pain Management, Anesthesiology, Occupational Medicine and
Rehabilitation, Neurology, Neurosurgery, Family Practice and Chiropractic.
THE DRAMATIC RESULTS OF VAX-D NON-SURGICAL DISC DECOMPRESSION
Peer Review Studies Published in Medical Journals
Outcomes After a Prone Lumbar Traction Protocol for Patients With Activity-Limiting Low Back Pain: A Prospective Case Series
Study
Paul F. Beattie, PhD, PT, OCS,
Roger M. Nelson, PhD, PT, Lori A. Michener, PhD, PT, ATC, SCS, Joseph Cammarata, DC,
Jonathan Donley, DPT
Archives of Physical Medicine And Rehabilitation, Volume 89, February 2008
A two-year study sponsored by Independence Blue Cross has just been released in 2008. The
purpose was to determine short- and long-term outcomes after VAX-D treatment in a large sample of patients with activity-limiting low back pain
that had failed at least two previous, non-surgical treatments. The study showed that patients had significantly improved pain and
disability scores at the end of treatment, at 30 days and at 180 days post-discharge.
JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY (Volume 35 Number 1, January 2005)
SHORT AND LONG TERM OUTCOMES FOLLOWING TREATMENT WITH THE VAX-D PROTOCOL FOR PATIENTS WITH CHRONIC,
ACTIVITY LIMITING LOW BACK PAIN
University South Carolina, Columbia, SC; Lebanon Valley College, Lancaster, PA; Virginia Commonwealth University, Richmond, VA
OUTCOME: Significant improvements in a sample of patients with unfavorable prognosis due to chronic low back pain.
JOURNAL OF NEUROLOGICAL RESEARCH (Volume 26 April, 2004)
EFFICACY OF VERTEBRAL AXIAL DECOMPRESSION ON CHRONIC LOW BACK PAIN
Dr. Gustavo Ramos, Valley Neurological Center, McAllen , Texas
OUTCOME: This 144 patient study showed 76% achieved remission of pain. VAX-D should be used in all patients before surgery is undertaken,
except in emergent conditions.
ANESTHESIOLOGY NEWS, (March 2003), A FOUR YEAR FOLLOW-UP STUDY
Robert H. Odell, MD, Ph. D, Daniel A. Boudreau, D.O.
OUTCOME: Four year follow-up after VAX-D treatment shows a sustained 86% reduction in pain and that
91% of patients had resumed their normal activities.
JOURNAL OF NEUROSURGERY (VOL 81: 350-353, 1994)
EFFECTS OF VERTEBRAL AXIAL DECOMPRESSION ON INTRADISCAL PRESSURE
University of Texas, San Antonio, Texas
OUTCOME: Proof that VAX-D actually creates a negative intradiscal pressure force up to negative 160 mm of mercury.
NEUROLOGICAL RESEARCH JOURNAL (October 2001,Volume 23, Page 706 to 714)
DERMATOMAL SOMATOSENSORY EVOKED POTENTIAL DEMONSTRATION OF NERVE ROOT DECOMPRESSION
AFTER VAX-D THERAPY William K. Naguszewski M.D. Robert K. Naguszewski M.D., Coosa Medical Group, Earl E Gose Ph.D.
Dept. of Neurology, Dept. of Bioengineering, University of Illinois
OUTCOME: Pain reduction in the study group was 77% with successful decompression of the nerve roots at multiple levels.
NEUROLOGICAL RESEARCH JOURNAL (October 2001, Volume 23, Page 780 to 784)
A PROSPECTIVE RANDOMIZED CONTROLLED STUDY OF VAX-D AND TENS FOR THE TREATMENT OF CHRONIC LOW BACK PAIN
Department of Orthopedics, Sydney University, Eugene Sherry M.D., FRACS, Peter Kitchener M.B. B.S. FRANZCR , Russel Smart M.B. Ch.B.
OUTCOME: A statistically significant reduction in pain and improvement in functional outcome was obtained in patients with chronic low back pain
treated with VAX-D.
CANADIAN JOURNAL OF CLINICAL MEDICINE (VOL 6 NO.1, JANUARY,1999)
THE EFFECTS OF VERTEBRAL AXIAL DECOMPRESSION ON SENSORY
NERVE DYSFUNCTION IN PATIENTS WITH LOW BACK PAIN AND RADICULOPATHY
by Tilaro & MIscovich
OUTCOME: VAX-D is significantly capable of influencing sensory nerve dysfunction associated with a compressive radiculopathy. Complete
remission was achieved by 64% of the study group.
CANADIAN JOURNAL OF CLINICAL MEDICINE (VOL 5 NUMBER 1, 1998)
AN OVERVIEW OF VERTEBRAL AXIAL DECOMPRESSION
by Frank Tilaro, M.D.
OUTCOME: The average pain reduction was 77%.
JOURNAL OF NEUROLOGICAL RESEARCH (Volume 20 , April 1998)
VERTEBRAL AXIAL DECOMPRESSION THERAPY FOR PAIN ASSOCIATED WITH HERNIATED OR DEGENERATIVE DISCS OR FACET SYNDROME: AN OUTCOME STUDY OF 778 CASES
OUTCOME: The authors consider VAX-D to be a primary modality for low back pain for lumbar herniation at single and multiple levels, degenerative
disc disease and facet arthropathy, and decreased spine mobility .
|
